Allergen immunotherapy (AIT) is a causative treatment for various allergic diseases such as allergic rhinitis, allergic asthma, and bee venom allergy that induces tolerance to offending allergens. The need for uniform practice guidelines in AIT is continuously growing because of the increasing discovery of potential candidates for AIT and evolving interest in new therapeutic approaches. This guideline is an updated version of the Korean Academy of Asthma Allergy and Clinical Immunology recommendations for AIT published in 2010. This updated guideline proposes an expert opinion by allergy, pediatrics, and otorhinolaryngology specialists with an extensive literature review. The guideline deals with basic knowledge and methodological aspects of AIT, including mechanisms, clinical efficacy, patient selection, allergens extract selection, schedule and doses, management of adverse reactions, efficacy measurements, and special consideration in pediatrics. The guidelines for sublingual immunotherapy will be covered in detail in a separate article.
KAAACI Guidelines for Allergen Immunotherapy
Hwa Young Lee,Sang Min Lee,Sung-Yoon Kang,Kyunghoon Kim,Ju Hee Kim,Gwanghui Ryu,Jin-Young Min,K. Park,So-Young Park,M. Sung,Youngsoo Lee,Eun-Ae Yang,H. Jee,E. K. Ha,Y. Shin,E. Chung,Sun Hee Choi,Young-Il Koh,Seon Tae Kim,D. Nahm,Jung-Won Park,J. Shim,Young Min An,D. Han,M. Han,Yong Won Lee,Jeong-Hee Choi
Published 2023 in Allergy Asthma and Immunology Research
ABSTRACT
PUBLICATION RECORD
- Publication year
2023
- Venue
Allergy Asthma and Immunology Research
- Publication date
2023-10-26
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-16 of 16 citing papers · Page 1 of 1